Literature DB >> 9354696

Wilms tumor gene (wt1) mRNA is equally expressed in blast cells from acute myeloid leukemia and normal CD34+ progenitors.

U Maurer, E Weidmann, T Karakas, D Hoelzer, L Bergmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354696

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  The possible role and application of WT1 in human leukemia.

Authors:  Z Chen
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.490

Review 2.  The characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseases.

Authors:  Changjin Yuan; Guanhua Song; Guosheng Jiang
Journal:  Intractable Rare Dis Res       Date:  2012-05

3.  Tumor-associated antigens in breast cancer.

Authors:  Carmen Criscitiello
Journal:  Breast Care (Basel)       Date:  2012-08       Impact factor: 2.860

Review 4.  Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene.

Authors:  Vicki Huff
Journal:  Nat Rev Cancer       Date:  2011-01-20       Impact factor: 60.716

Review 5.  Status of minimal residual disease testing in childhood haematological malignancies.

Authors:  Dario Campana
Journal:  Br J Haematol       Date:  2008-08-15       Impact factor: 6.998

Review 6.  Wilms tumor gene (WT1) expression as a panleukemic marker.

Authors:  Hans D Menssen; Jan M Siehl; Eckhard Thiel
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  Homology modeling and molecular dynamics studies of Wilms' tumor gene 1 frameshift mutations in exon 7.

Authors:  Shaoyan Hu; Ying Wang; Shuiyan Wu; Mingying Zhang; Jian Pan; Hongjie Shen; Xiaofei Qi; Jiannong Cen; Zixing Chen; Bairong Shen; Ruihua Chen
Journal:  Biomed Rep       Date:  2013-07-22

8.  Wilms' Tumour gene 1 (WT1) as an immunotherapeutic target.

Authors:  A Coosemans
Journal:  Facts Views Vis Obgyn       Date:  2011
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.